Nutritional Status as a Risk Factor for New-Onset Atrial Fibrillation in Acute Myocardial Infarction

References

• Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038–1045. doi:10.1093/eurheartj/ehn579
   PubMed Web of Science ®Google Scholar
• Angeli F, Reboldi G, Garofoli M, et al. Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr Cardiol Rep. 2012;14(5):601–610. doi:10.1007/s11886-012-0289-3
   PubMed Web of Science ®Google Scholar
• Rathore SS, Berger AK, Weinfurt KP, et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101(9):969–974. doi:10.1161/01.CIR.101.9.969
   PubMed Web of Science ®Google Scholar
• Komici K, Vitale DF, Mancini A, et al. Impact of malnutrition on long-term mortality in elderly patients with acute myocardial infarction. Nutrients. 2019;11(2):224. doi:10.3390/nu11020224
   PubMed Web of Science ®Google Scholar
• Nakamura T, Haraguchi Y, Matsumoto M, Ishida T, Momomura SI. Prognostic impact of malnutrition in elderly patients with acute myocardial infarction. Heart Vessels. 2022;37(3):385–391. doi:10.1007/s00380-021-01922-y
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2016;67(10):1235–1250. doi:10.1016/j.jacc.2015.10.005
   PubMed Web of Science ®Google Scholar
• DeGeare VS, Boura JA, Grines LL, O’Neill WW, Grines CL. Predictive value of the killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2001;87:1035–1038. doi:10.1016/S0002-9149(01)01457-6
   PubMed Web of Science ®Google Scholar
• Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20(1):38–45.
   PubMedGoogle Scholar
• Luo J, Liu B, Li H, et al. Prognostic impact of the symptom of new-onset atrial fibrillation in acute myocardial infarction: insights from the NOAFCAMI-SH registry. Front Cardiovasc Med. 2021;8:677695. doi:10.3389/fcvm.2021.677695
   PubMedGoogle Scholar
• Kim D, Shim J, Kim YG, et al. Malnutrition and risk of procedural complications in patients with atrial fibrillation undergoing catheter ablation. Front Cardiovasc Med. 2021;8:736042. doi:10.3389/fcvm.2021.736042
   PubMed Web of Science ®Google Scholar
• Bouillanne O, Morineau G, Dupont C, et al. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82(4):777–783. doi:10.1093/ajcn/82.4.777
   PubMed Web of Science ®Google Scholar
• Bishara R, Telman G, Bahouth F, Lessick J, Aronson D. Transient atrial fibrillation and risk of stroke after acute myocardial infarction. Thromb Haemost. 2011;106(5):877–884. doi:10.1160/TH11-05-0343
   PubMed Web of Science ®Google Scholar
• Zhu S, Zhao H, Zheng M, Peng J. The impact of malnutrition on atrial fibrillation recurrence post ablation. Nutr Metab Cardiovasc Dis. 2021;31(3):834–840. doi:10.1016/j.numecd.2020.12.003
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim SH, Lee W, et al. New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke. BMJ Open. 2020;10(9):e039600. doi:10.1136/bmjopen-2020-039600
   PubMed Web of Science ®Google Scholar
• Shiyovich A, Axelrod M, Gilutz H, Plakht Y. Early versus late new-onset atrial fibrillation in acute myocardial infarction: differences in clinical characteristics and predictors. Angiology. 2019;70(10):921–928. doi:10.1177/0003319719867542
   PubMed Web of Science ®Google Scholar
• Wi J, Shin DH, Kim JS, et al. Transient new-onset atrial fibrillation is associated with poor clinical outcomes in patients with acute myocardial infarction. Circ J. 2016;80(7):1615–1623. doi:10.1253/circj.CJ-15-1250
   PubMed Web of Science ®Google Scholar
• Kinjo K, Sato H, Sato H, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92(10):1150–1154. doi:10.1016/j.amjcard.2003.07.021
   PubMed Web of Science ®Google Scholar
• Luo J, Xu S, Li H, et al. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure. ESC Heart Fail. 2020;7(5):2762–2772. doi:10.1002/ehf2.12872
   PubMed Web of Science ®Google Scholar
• Fauchier L, Bisson A, Bodin A, et al. Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis. Clin Res Cardiol. 2021;110(9):1431–1438. doi:10.1007/s00392-021-01805-2
   PubMed Web of Science ®Google Scholar
• Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501–1517. doi:10.1161/CIRCRESAHA.117.309732
   PubMed Web of Science ®Google Scholar
• Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res. 2020;127(1):4–20. doi:10.1161/CIRCRESAHA.120.316340
   PubMed Web of Science ®Google Scholar
• Fu Y, Pan Y, Gao Y, Yang X, Chen M. Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction. BMC Cardiovasc Disord. 2021;21(1):175. doi:10.1186/s12872-021-01978-8
   PubMedGoogle Scholar
• Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011;123(15):1587–1593. doi:10.1161/CIRCULATIONAHA.110.986661
   PubMed Web of Science ®Google Scholar
• He J, Yang Y, Zhang G, Lu XH. Clinical risk factors for new-onset atrial fibrillation in acute myocardial infarction: a systematic review and meta-analysis. Medicine. 2019;98(26):e15960. doi:10.1097/MD.0000000000015960
   PubMed Web of Science ®Google Scholar
• Yi JE, Seo SM, Lim S, et al. Gender differences in the impact of new-onset atrial fibrillation on long-term risk of ischemic stroke after acute myocardial infarction. J Clin Med. 2021;10(21):5141. doi:10.3390/jcm10215141
   PubMed Web of Science ®Google Scholar
• Wang J, Yang YM, Zhu J. Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome. Herz. 2015;40:18–26. doi:10.1007/s00059-014-4149-3
   PubMed Web of Science ®Google Scholar
• Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–57. doi:10.1016/j.jjcc.2020.12.013
   PubMed Web of Science ®Google Scholar
• Hisatome I, Li P, Miake J, et al. Uric acid as a risk factor for chronic kidney disease and cardiovascular disease – Japanese guideline on the management of asymptomatic hyperuricemia. Circ J. 2021;85(2):130–138. doi:10.1253/circj.CJ-20-0406
   PubMed Web of Science ®Google Scholar
• Kawasoe S, Kubozono T, Yoshifuku S, et al. Uric acid level and new-onset atrial fibrillation in the Japanese general population – longitudinal study. Circ J. 2018;83(1):156–163. doi:10.1253/circj.CJ-18-0508
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang XD, Yao JW, et al. The impact of the duration of cardiac troponin I elevation on the clinical prognosis as well as incidence of new-onset atrial fibrillation respectively in elderly non-ST-elevation acute myocardial infarction patients without PCI. J Inflam Res. 2021;14:6907–6916. doi:10.2147/JIR.S345576
   PubMed Web of Science ®Google Scholar
• Chow SL, Maisel AS, Anand I, et al. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American heart association. Circulation. 2017;135(22):e1054–e1091. doi:10.1161/CIR.0000000000000490
   PubMed Web of Science ®Google Scholar
• Tsutsui H, Isobe M, Ito H, et al. JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure – digest version. Circ J. 2019;83(10):2084–2184. doi:10.1253/circj.CJ-19-0342
   PubMed Web of Science ®Google Scholar
• Nagata T, Hata J, Sakata S, et al. Serum N-terminal pro-B-type natriuretic peptide as a predictor for future development of atrial fibrillation in a general population: the hisayama study. Int J Cardiol. 2020;320:90–96. doi:10.1016/j.ijcard.2020.06.018
   PubMed Web of Science ®Google Scholar
• Asselbergs FW, van den Berg MP, Bakker SJ, et al. N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort. Neth Heart J. 2008;16(3):73–78. doi:10.1007/BF03086122
   PubMed Web of Science ®Google Scholar
• Schnabel RB, Larson MG, Yamamoto JF, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010;121(2):200–207. doi:10.1161/CIRCULATIONAHA.109.882241
   PubMed Web of Science ®Google Scholar
• Dorje T, Wang X, Shao M, et al. Plasma N-terminal pro-brain natriuretic peptide levels predict new-onset atrial fibrillation in patients with acute myocardial infarction. Int J Cardiol. 2013;168(3):3135–3137. doi:10.1016/j.ijcard.2013.04.032
   PubMed Web of Science ®Google Scholar
• Asanin M, Stankovic S, Mrdovic I, et al. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Peptides. 2012;35(1):74–77. doi:10.1016/j.peptides.2012.02.022
   PubMed Web of Science ®Google Scholar
• Bahouth F, Mutlak D, Furman M, et al. Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction. Heart. 2010;96(9):683–688. doi:10.1136/hrt.2009.183822
   PubMed Web of Science ®Google Scholar
• Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated langendorff-perfused rabbit heart. Circulation. 1997;96:1686–1695. doi:10.1161/01.CIR.96.5.1686
   PubMed Web of Science ®Google Scholar
• Gomes F, Schuetz P, Bounoure L, et al. ESPEN guidelines on nutritional support for polymorbid internal medicine patients. Clin Nutr. 2018;37(1):336–353. doi:10.1016/j.clnu.2017.06.025
   PubMed Web of Science ®Google Scholar
• Felder S, Braun N, Stanga Z, et al. Unraveling the link between malnutrition and adverse clinical outcomes: association of acute and chronic malnutrition measures with blood biomarkers from different pathophysiological states. Ann Nutr Metab. 2016;68(3):164–172. doi:10.1159/000444096
   PubMed Web of Science ®Google Scholar
• Schuetz P, Seres D, Lobo DN, Gomes F, Kaegi-Braun N, Stanga Z. Management of disease-related malnutrition for patients being treated in hospital. Lancet. 2021;398(10314):1927–1938. doi:10.1016/S0140-6736(21)01451-3
   PubMed Web of Science ®Google Scholar
• Adejumo AC, Adejumo KL, Adegbala OM, et al. Inferior outcomes of patients with acute myocardial infarction and comorbid protein-energy malnutrition. JPEN J Parenter Enter Nutr. 2020;44(3):454–462. doi:10.1002/jpen.1680
   PubMed Web of Science ®Google Scholar
• Takahashi T, Watanabe T, Otaki Y, et al. Prognostic significance of the controlling nutritional (CONUT) score in patients with acute coronary syndrome. Heart Vessels. 2021;36(8):1109–1116. doi:10.1007/s00380-021-01792-4
   PubMed Web of Science ®Google Scholar
• Kato T, Yaku H, Morimoto T, et al. Association with Controlling Nutritional Status (CONUT) score and in-hospital mortality and infection in acute heart failure. Sci Rep. 2020;10(1):3320. doi:10.1038/s41598-020-60404-9
   PubMed Web of Science ®Google Scholar
• Ruan GT, Zhang Q, Zhang X, et al. Geriatric nutrition risk index: prognostic factor related to inflammation in elderly patients with cancer cachexia. J Cachexia Sarcopenia Muscle. 2021;12(6):1969–1982. doi:10.1002/jcsm.12800
   PubMed Web of Science ®Google Scholar
• Díez-Manglano J, Clemente-Sarasa C. The nutritional risk and short-, medium- and long-term mortality of hospitalized patients with atrial fibrillation. Aging Clin Exp Res. 2019;31(12):1775–1781. doi:10.1007/s40520-019-01152-3
   PubMed Web of Science ®Google Scholar
• Furui K, Morishima I, Morita Y, et al. Impact of preoperative nutritional status on the outcome of catheter ablation for atrial fibrillation. Circ J. 2022;86(2):268–276. doi:10.1253/circj.CJ-21-0218
   PubMed Web of Science ®Google Scholar
• Çinier G, Hayıroğlu Mİ, Kolak Z, et al. The value of C-reactive protein-to-albumin ratio in predicting long-term mortality among HFrEF patients with implantable cardiac defibrillators. Eur J Clin Invest. 2021;51(8):e13550. doi:10.1111/eci.13550
   PubMed Web of Science ®Google Scholar
• Çınar T, Hayıroğlu Mİ, Çiçek V, et al. Is prognostic nutritional index a predictive marker for estimating all-cause in-hospital mortality in COVID-19 patients with cardiovascular risk factors? Heart Lung. 2021;50(2):307–312. doi:10.1016/j.hrtlng.2021.01.006
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Çınar T, Çinier G, et al. Prognostic value of serum albumin for long-term mortality in patients with dual-chamber permanent pacemakers. Biomark Med. 2022;16(5):341–348. doi:10.2217/bmm-2021-0991
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Çınar T, Çinier G, et al. Cardiac variables associated with atrial fibrillation occurrence and mortality in octogenarians implanted with dual chamber permanent pacemakers. Aging Clin Exp Res. 2022;34(10):2533–2539. doi:10.1007/s40520-022-02194-w
   PubMed Web of Science ®Google Scholar
• Wang Y, Du P, Xiao Q, et al. Relationship between serum albumin and risk of atrial fibrillation: a dose-response meta-analysis. Front Nutr. 2021;8:728353. doi:10.3389/fnut.2021.728353
   PubMed Web of Science ®Google Scholar
• Liao LZ, Zhang SZ, Li WD, et al. Serum albumin and atrial fibrillation: insights from epidemiological and mendelian randomization studies. Eur J Epidemiol. 2020;35(2):113–122. doi:10.1007/s10654-019-00583-6
   PubMed Web of Science ®Google Scholar
• Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007;115(2):135–143. doi:10.1016/j.ijcard.2006.04.026
   PubMed Web of Science ®Google Scholar
• Arques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail. 2011;17(6):451–458. doi:10.1016/j.cardfail.2011.02.010
   PubMed Web of Science ®Google Scholar
• Anaszewicz M, Budzyński J. Clinical significance of nutritional status in patients with atrial fibrillation: an overview of current evidence. J Cardiol. 2017;69(5):719–730. doi:10.1016/j.jjcc.2016.06.014
   PubMed Web of Science ®Google Scholar
• Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet. 2000;356(9233):930–933. doi:10.1016/S0140-6736(00)02690-8
   PubMed Web of Science ®Google Scholar
• Barallobre-Barreiro J, Gupta SK, Zoccarato A, et al. Glycoproteomics reveals decorin peptides with anti-myostatin activity in human atrial fibrillation. Circulation. 2016;134(11):817–832. doi:10.1161/CIRCULATIONAHA.115.016423
   PubMed Web of Science ®Google Scholar
• Yan YQ, Zou LJ. Relation between zinc, copper, and magnesium concentrations following cardiopulmonary bypass and postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Biol Trace Elem Res. 2012;148(2):148–153. doi:10.1007/s12011-012-9356-2
   PubMed Web of Science ®Google Scholar
• Demir M, Uyan U, Melek M. The effects of vitamin D deficiency on atrial fibrillation. Clin Appl Thromb Hemost. 2014;20(1):98–103. doi:10.1177/1076029612453762
   PubMed Web of Science ®Google Scholar
• Greenberg JW, Lancaster TS, Schuessler RB, Melby SJ. Postoperative atrial fibrillation following cardiac surgery: a persistent complication. Eur J Cardiothorac Surg. 2017;52(4):665–672. doi:10.1093/ejcts/ezx039
   PubMed Web of Science ®Google Scholar
• Goldman SM. Commentary: postoperative atrial fibrillation: “no magic bullet”. J Thorac Cardiovasc Surg. 2021;161(5):1812–1813. doi:10.1016/j.jtcvs.2019.11.067
   PubMed Web of Science ®Google Scholar